WITHDRAWN: SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway
| Autor: | Wencheng Fang, Xiangting Guo, Wei Dai, Shoukai Zong, Kai Wang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Cisplatin medicine.diagnostic_test Chemistry Biophysics Cell Biology medicine.disease Biochemistry Flow cytometry 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer Apoptosis Anaerobic glycolysis 030220 oncology & carcinogenesis Cancer research medicine Glycolysis Molecular Biology Protein kinase B PI3K/AKT/mTOR pathway medicine.drug |
| Zdroj: | Bioscience Reports. |
| ISSN: | 1573-4935 0144-8463 |
| DOI: | 10.1042/bsr20201302 |
| Popis: | Objective This study aimed to investigate the effect of SIK2 on cisplatin resistance induced by aerobic glycolysis in breast cancer cells and its potential mechanism. Methods qRT-PCR and Western blot were used to detect SIK2 mRNA and protein levels. Cisplatin (DDP) resistant cell lines of breast cancer cells were established, CCK-8 was used to measure and evaluate the viability, and Transwell was used to evaluate the cell invasion capability. Flow cytometry was adopted to evaluate the apoptosis rate. The glycolysis level was evaluated by measuring glucose consumption and lactic acid production. The protein levels of p-PI3K, p- protein kinase B (Akt) and p-mTOR were determined by western blot. Results SIK2 is highly expressed in breast cancer tissues and cells compared with adjacent tissues and normal human breast epithelial cells, and has higher diagnostic value for breast cancer. Silencing SIK2 expression can inhibit proliferation and invasion of breast cancer cells and induce their apoptosis. In addition, SIK2 knockdown inhibits glycolysis, reverses the resistance of drug-resistant cells to cisplatin, and inhibits PI3K/AKT/mTOR signaling pathway. When LY294002 is used to inhibit PI3K/AKT/mTOR signaling pathway, the effect of Sh-SIK2 on aerobic glycolysis of breast cancer cells can be reversed. Conclusion SIK2 can promote cisplatin resistance caused by aerobic glycolysis of breast cancer cells through PI3K/AKT/mTOR signaling pathway, which may be a new target to improve cisplatin resistance of breast cancer cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|